Results 191 to 200 of about 493,439 (210)
Some of the next articles are maybe not open access.

Treatment Outcome of Atypical EGFR Mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Annals of Oncology, 2022
Melanie Janning   +2 more
exaly  

Anti-EGFR-Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-Challenge

Annals of Oncology, 2019
Eduardo Vilar   +2 more
exaly  

Poor Response to Erlotinib in Patients With Tumors Containing Baseline EGFR T790M Mutations Found by Routine Clinical Molecular Testing

Annals of Oncology, 2014
Gregory J Riely   +2 more
exaly  

Outcome of Advanced NSCLC Patients Harboring Sensitizing EGFR Mutations Randomized to EGFR Tyrosine Kinase Inhibitors or Chemotherapy as First-Line Treatment: A Meta-Analysis

Annals of Oncology, 2011
Isabella Sperduti   +2 more
exaly  

An Evaluation Study of EGFR Mutation Tests Utilized for Non-Small-Cell Lung Cancer in the Diagnostic Setting

Annals of Oncology, 2012
Tetsuya Mitsudomi, G Ishii, K Hagiwara
exaly  

Overall Survival With Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

New England Journal of Medicine, 2020
Jean-Charles Soria   +2 more
exaly  

Implications for KRAS Status and EGFR-Targeted Therapies in Metastatic CRC

Nature Reviews Clinical Oncology, 2009
Antonella De Luca   +2 more
exaly  

Identification of Plasma microRNA Profiles for Primary Resistance to EGFR-TKIs in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With EGFR Activating Mutation

Journal of Hematology and Oncology, 2015
Minglei Zhuo, Meina Wu
exaly  

Impact of EGFR Expression on Colorectal Cancer Patient Prognosis and Survival

Annals of Oncology, 2005
Robert Benamouzig, J-P Spanò, J Domont
exaly  

Activity of the Hsp90 Inhibitor Luminespib Among Non-Small-Cell Lung Cancers Harboring EGFR Exon 20 Insertions

Annals of Oncology, 2018
Daniel B Costa, J F Gainor, L V Sequist
exaly  
previous   18  19  20  21  

Home - About - Disclaimer - Privacy